Seattle Washington based Bonum Therapeutics is raising $93,041,420.00 in New Equity Investment.
Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Bonum Therapeutics is raising $93,041,420.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, John Mulligan played a…
